Condition

Colo-rectal Cancer

ClinicalTrials.gov condition label

Clinical trials33
Recruiting8
Common interventions25
Lead sponsors shown15

Clinical trials

33 shown
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsNCT07145255 · 2025-09-03
RECRUITING
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsNCT07085091 · 2025-08-18
RECRUITING
tislelizUMaB in canceR Patients With molEcuLar residuaL DiseaseNCT06332274 · 2025-04-16
RECRUITING
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialNCT06563388 · 2024-09-18
RECRUITING
A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer RisksNCT07469709 · 2024-02-01
RECRUITING
PRE-ISPY Phase I/II Oncology Platform ProgramNCT05868226 · 2023-02-15
RECRUITING
Engineered TILs/CAR-TILs to Treat Advanced Solid TumorsNCT04842812 · 2021-01-01
RECRUITING
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsNCT03755739 · 2018-11-01
RECRUITING
Effectiveness of a Mobile Health Management Program for Colorectal Cancer Survivors With Chronic ConditionsNCT06759844 · 2025-01-01
UNKNOWN
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D MutationNCT05737706 · 2023-03-06
TERMINATED
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)NCT05708950 · 2023-03-03
COMPLETED
A Phase 1 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK PathwayNCT05578092 · 2022-12-02
TERMINATED
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsNCT05572684 · 2022-10-06
TERMINATED
Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in OncologyNCT05354882 · 2022-03-29
UNKNOWN
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)NCT05121948 · 2022-02-23
TERMINATED
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsNCT05124743 · 2021-09-24
TERMINATED
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory FunctionNCT04799080 · 2021-03-06
COMPLETED
Implementing Acupuncture and Chinese Herbal Medicine Into Palliative CareNCT04584775 · 2021-02-01
WITHDRAWN
Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorectal Cancer SurgeryNCT07756450 · 2021-01-01
COMPLETED
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid TumorsNCT04073680 · 2020-09-01
UNKNOWN
Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care PolicyNCT04588909 · 2020-03-23
UNKNOWN
Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male VolunteersNCT05800418 · 2019-11-04
COMPLETED
Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)NCT03849950 · 2019-06-11
TERMINATED
Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)NCT04065984 · 2019-04-14
UNKNOWN
Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer OriginNCT03960021 · 2019-03-04
TERMINATED
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerNCT03775525 · 2019-03-01
UNKNOWN
Study of ADCT-301 in Patients With Selected Advanced Solid TumorsNCT03621982 · 2018-11-09
TERMINATED
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.NCT03667716 · 2018-09-06
COMPLETED
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNCT03602079 · 2018-07-16
COMPLETED
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNANCT04104633 · 2018-06-14
COMPLETED
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid TumorsNCT03129139 · 2017-10-10
UNKNOWN
Cancer Mortality Affected by the Choice of Anesthetic Drugs?NCT01418326 · 2010-11-01
COMPLETED
The French E3N Prospective Cohort StudyNCT03285230 · 1990-06-15
ACTIVE_NOT_RECRUITING

Common interventions

A166DRUG1ADCDRUG1ADCT-301DRUG1ALX148DRUG1ALX2004DRUG1Best PracticeOTHER1Blood samplesPROCEDURE1Blood samplingOTHER1Canagliflozin 300mgDRUG1CapecitabineDRUG1Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapyDRUG1Colorectal resectionsPROCEDURE1COM701DRUG1COM701 with Opdivo (Nivolumab).DRUG1ControlOTHER1Educational BookletBEHAVIORAL1Fam-Trastuzumab Deruxtecan-NxkiDRUG1GZ17-6.02DRUG1HC-7366DRUG1KVA12123 - Dose EscalationDRUG1KVA12123 - Dose ExpansionDRUG1KVA12123 Plus Pembrolizumab - Dose EscalationDRUG1KVA12123 Plus Pembrolizumab - Dose ExpansionDRUG1Microstim 2v2 StimulatorDEVICE1Minnelide™CapsulesDRUG1

Trial status mix

COMPLETED8
RECRUITING8
TERMINATED8
UNKNOWN7
ACTIVE_NOT_RECRUITING1
WITHDRAWN1

Phase mix

PHASE116
NA7
PHASE27
PHASE33

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.